Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970083 · ClinicalTrials.gov registry record
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer
A clinical trial of Cervical Cancer and Gynecologic Cancer, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT03970083: Active study of Cervical Cancer and Gynecologic Cancer, sponsored by Dana-Farber Cancer Institute.
NCT03970083 is a study of Cervical Cancer and Gynecologic Cancer that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970083, a study of Cervical Cancer and Gynecologic Cancer, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is studying the level of oxygen in tumors during the brachytherapy procedure.
Conditions Studied
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2025-09-30 |
What the registry record for NCT03970083 still lists
NCT03970083 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03970083 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03970083 about?
NCT03970083 is a clinical study titled "A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer". This research is studying the level of oxygen in tumors during the brachytherapy procedure.
What is the current status of trial NCT03970083?
This trial is currently active not recruiting. The enrollment target is 10 participants. The study started on 2019-07-16. Estimated completion is 2025-09-30.
What conditions does trial NCT03970083 study?
This clinical trial studies the following conditions: Cervical Cancer, Gynecologic Cancer.
Who is sponsoring clinical trial NCT03970083?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03970083 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03970083's enrollment target sits among peer trials
10 143rd of 144 higher than 1 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
RECRUITING
-
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
RECRUITING · Phase 2
-
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 2
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
PopSci CHW4CervixHealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI